Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
ProQR Therapeutics N.V. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $137.58M | $78.88M - $175.59M | -$137.58M | $0.034 | 1 |
| Dec 2029 | $72.01M | $41.28M - $91.90M | -$72.01M | -$0.31 | 2 |
| Dec 2028 | $59.25M | $57.72M - $60.78M | -$59.25M | -$0.295 | 3 |
| Dec 2027 | $16.96M | $10.21M - $23.34M | -$16.96M | -$0.598 | 5 |
| Dec 2026 | $20.83M | $18.29M - $24.07M | -$20.83M | -$0.516 | 5 |
| Dec 2025 | $16.24M | $11.51M - $22.52M | -$16.24M | -$0.406 | 4 |
| Dec 2024 | $17.45M | $12.80M - $24.80M | -$17.45M | -$0.333 | 5 |
| Dec 2023 | $14.70M | $8.43M - $18.76M | -$14.70M | -$0.247 | 2 |
| Dec 2022 | $22.14M | $13.53M - $29.27M | -$56.56M | -$0.935 | 1 |
| Dec 2021 | $2.57M | $1.57M - $3.40M | -$43.37M | -$0.901 | 2 |
| Dec 2020 | $9.30M | $5.68M - $12.29M | -$37.05M | -$0.918 | 2 |
| Dec 2019 | $1.99M | $1.22M - $2.64M | -$48.84M | -$1.343 | 1 |